186 related articles for article (PubMed ID: 37715192)
1. Sex differences in renal cell carcinoma: a single-cell analysis reveals exhausted CD8
Ning K; Peng Y; Jiang Y; Li Z; Luo X; Lin L; Deng M; Wu Y; Huang T; Huang Y; Xie Y; Yang X; Zhang M; Xiong L; Zou X; Zhou Z; Zhou F; Dong P; Yu C; Zhang Z
Biol Sex Differ; 2023 Sep; 14(1):58. PubMed ID: 37715192
[TBL] [Abstract][Full Text] [Related]
2. Single-cell transcriptomics reveals a low CD8
Peng YL; Xiong LB; Zhou ZH; Ning K; Li Z; Wu ZS; Deng MH; Wei WS; Wang N; Zou XP; He ZS; Huang JW; Luo JH; Liu JY; Jia N; Cao Y; Han H; Guo SJ; Dong P; Yu CP; Zhou FJ; Zhang ZL
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35121646
[TBL] [Abstract][Full Text] [Related]
3. A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma.
Pichler R; Siska PJ; Tymoszuk P; Martowicz A; Untergasser G; Mayr R; Weber F; Seeber A; Kocher F; Barth DA; Pichler M; Thurnher M
Front Immunol; 2023; 14():1095195. PubMed ID: 37006314
[TBL] [Abstract][Full Text] [Related]
4. Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma.
Lee MH; Theodoropoulos J; Huuhtanen J; Bhattacharya D; Järvinen P; Tornberg S; Nísen H; Mirtti T; Uski I; Kumari A; Peltonen K; Draghi A; Donia M; Kreutzman A; Mustjoki S
Cancer Res Commun; 2023 Jul; 3(7):1260-1276. PubMed ID: 37484198
[TBL] [Abstract][Full Text] [Related]
5. Renal Cell Carcinoma-Infiltrating CD3
Lee HW; Park C; Joung JG; Kang M; Chung YS; Oh WJ; Yeom SY; Park WY; Kim TJ; Seo SI
Curr Issues Mol Biol; 2021 May; 43(1):226-239. PubMed ID: 34071865
[TBL] [Abstract][Full Text] [Related]
6. Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR) → c-Myc signals.
Song W; Li L; He D; Xie H; Chen J; Yeh CR; Chang LS; Yeh S; Chang C
Cancer Lett; 2015 Nov; 368(1):71-78. PubMed ID: 26231735
[TBL] [Abstract][Full Text] [Related]
7. Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile.
Adorno Febles VR; Hao Y; Ahsan A; Wu J; Qian Y; Zhong H; Loeb S; Makarov DV; Lepor H; Wysock J; Taneja SS; Huang WC; Becker DJ; Balar AV; Melamed J; Deng FM; Ren Q; Kufe D; Wong KK; Adeegbe DO; Deng J; Wise DR
Prostate; 2023 Jun; 83(9):840-849. PubMed ID: 36988342
[TBL] [Abstract][Full Text] [Related]
8. Androgen conspires with the CD8
Kwon H; Schafer JM; Song NJ; Kaneko S; Li A; Xiao T; Ma A; Allen C; Das K; Zhou L; Riesenberg B; Chang Y; Weltge P; Velegraki M; Oh DY; Fong L; Ma Q; Sundi D; Chung D; Li X; Li Z
Sci Immunol; 2022 Jul; 7(73):eabq2630. PubMed ID: 35420889
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of single-cell RNA-seq and bulk RNA-seq revealed the heterogeneity and convergence of the immune microenvironment in renal cell carcinoma.
Lv S; Tao L; Liao H; Huang Z; Lu Y
Funct Integr Genomics; 2023 Jun; 23(2):193. PubMed ID: 37264263
[TBL] [Abstract][Full Text] [Related]
10. Intracrine androgen biosynthesis in renal cell carcinoma.
Lee GT; Han CS; Kwon YS; Patel R; Modi PK; Kwon SJ; Faiena I; Patel N; Singer EA; Ahn HJ; Kim WJ; Kim IY
Br J Cancer; 2017 Mar; 116(7):937-943. PubMed ID: 28253524
[TBL] [Abstract][Full Text] [Related]
11. Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles.
Govindarajan A; Salgia NJ; Li H; Castro DV; Mirzapoiazova T; Armstrong B; Zhao D; Mercier BD; Dizman N; Chawla N; Zengin Z; Meza L; Tripathi N; Sayegh N; Chehrazi-Raffle A; Tripathi A; Pal SK
Front Immunol; 2023; 14():1182581. PubMed ID: 37638025
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor-mediated CD8
Yang C; Jin J; Yang Y; Sun H; Wu L; Shen M; Hong X; Li W; Lu L; Cao D; Wang X; Sun J; Ye Y; Su B; Deng L
Immunity; 2022 Jul; 55(7):1268-1283.e9. PubMed ID: 35700739
[TBL] [Abstract][Full Text] [Related]
13. Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma.
Chen WJ; Dong KQ; Pan XW; Gan SS; Xu D; Chen JX; Chen WJ; Li WY; Wang YQ; Zhou W; Rini B; Cui XG
Cell Death Dis; 2023 Jan; 14(1):30. PubMed ID: 36646679
[TBL] [Abstract][Full Text] [Related]
14. Tumour grade significantly correlates with total dysfunction of tumour tissue-infiltrating lymphocytes in renal cell carcinoma.
Kawashima A; Kanazawa T; Kidani Y; Yoshida T; Hirata M; Nishida K; Nojima S; Yamamoto Y; Kato T; Hatano K; Ujike T; Nagahara A; Fujita K; Morimoto-Okazawa A; Iwahori K; Uemura M; Imamura R; Ohkura N; Morii E; Sakaguchi S; Wada H; Nonomura N
Sci Rep; 2020 Apr; 10(1):6220. PubMed ID: 32277125
[TBL] [Abstract][Full Text] [Related]
15. Single-cell transcriptomics identify TNFRSF1B as a novel T-cell exhaustion marker for ovarian cancer.
Gao Y; Shi H; Zhao H; Yao M; He Y; Jiang M; Li J; Li Z; Su S; Liu T; Yin C; Liao X; Yue W
Clin Transl Med; 2023 Sep; 13(9):e1416. PubMed ID: 37712139
[TBL] [Abstract][Full Text] [Related]
16. Minimal changes in the systemic immune response after nephrectomy of localized renal masses.
Wald G; Barnes KT; Bing MT; Kresowik TP; Tomanek-Chalkley A; Kucaba TA; Griffith TS; Brown JA; Norian LA
Urol Oncol; 2014 Jul; 32(5):589-600. PubMed ID: 24768357
[TBL] [Abstract][Full Text] [Related]
17. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral CXCL13
Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528
[TBL] [Abstract][Full Text] [Related]
19. Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma.
Murakami T; Tanaka N; Takamatsu K; Hakozaki K; Fukumoto K; Masuda T; Mikami S; Shinojima T; Kakimi K; Tsunoda T; Sawada K; Imamura T; Mizuno R; Oya M
Cancer Immunol Immunother; 2021 Oct; 70(10):3001-3013. PubMed ID: 34259900
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood.
Carlisle JW; Jansen CS; Cardenas MA; Sobierajska E; Reyes AM; Greenwald R; Del Balzo L; Prokhnevska N; Kucuk O; Carthon BC; Mullane PC; Osunkoya A; Baumgarten D; Hosseinzadeh F; Wilkinson S; Lake R; Sowalsky AG; Liu Y; Master VA; Bilen MA; Kissick H
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35863822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
